Cellavision AB (CEVI) Ord NPV
Sell:163.40 SEKBuy:163.60 SEK
0.60 SEK
(0.36%)
- This stock can be held in a
Stocks and Shares ISA0.60 SEK
(0.36%)0.60 SEK
(0.36%)Company Information
About this company
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Key people
Key facts
- EPICCEVI
- LocationSweden
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINSE0000683484
- Market capSEK 3.94bn
- Employees228
- Shares in issue23.85m
- ExchangeStockholm Stock Exchange
- IndexSX All Share PI Market Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.